Akso Health Group
NASDAQ:AHGFinancial - Credit Services
+$0.03 today
- Market cap
- $1.16B
- Beta
- -1.02
- P/E (TTM)
- -3.1
- EPS (TTM)
- -$0.40
Volume 0.00M
Average 0.12M
AHG Capital Expenditures
Cash spent on property, plant, equipment, and other long-term assets.
Akso Health GroupNASDAQ: AHG
Capital Expenditures · Q4 FY2025 · quarter ended Mar 2025
Capital expenditures turns negative
Q4 FY2025 capital expenditures was -$12.14K, compared with $0 a year earlier. Trailing-twelve-month capital expenditures was -$154.46K. Over 3 fiscal years it compounded at +216.7% a year.
Context
- Capital expenditures amounted to 1.0% of revenue in FY2025, up 1.0 pp from a year earlier.
- Capital expenditures increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly capital expenditures holds near -$12.14K or moves back toward the trailing-twelve-month quarterly average of -$38.61K.
Sources:Cash FlowText generated from reported figures; not investment advice.
Capital Expenditures history
USD · from the cash flow
- Latest · FY2025
- (154.46K) USD
- Year-over-year change
- —
| Period | Period end | Capital Expenditures | YoY change |
|---|---|---|---|
| FY2025 | 2025-03-31 | (154.46K) | — |
| FY2024 | 2024-03-31 | 0 | — |
| FY2023 | 2023-03-31 | 0 | +100.0% |
| FY2022 | 2022-03-31 | (4.86K) | — |
| FY2021 | 2021-03-31 | 0 | — |
Capital Expenditures vs competitors
How AHG compares with its peers on the latest reported figures
- Peers report in different currencies, so capital expenditures is compared through growth and share of revenue rather than absolute size.
- Capital expenditures amounts to 1.0% of revenue for AHG, versus a peer median of 2.2%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | CN¥470.89M CNY | +74.9% | +81.3% | 4.6% | |
| LTM Mar 2026 | $4.4M USD | +2.1% | -25.2% | 2.2% | |
| LTM Mar 2025 | $154.46K USD | — | +216.7% | 1.0% | |
ZKHZKH Group Limited | LTM Jun 2025 | CN¥0 CNY | +100.0% | +1.0% | 0.0% |
| Peer median (excluding AHG) | — | +74.9% | +1.0% | 2.2% | |
Competitors are the stored peer set for AHG. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Mar 2021 | FY2022 Mar 2022 | FY2023 Mar 2023 | FY2024 Mar 2024 | FY2025 Mar 2025 |
|---|---|---|---|---|---|
| Net Income | (34.72M) | (16.85M) | (13.08M) | (9.12M) | (135.47M) |
| Depreciation & Amortization | 15.16K | 18.39K | 0 | 0 | 2.15M |
| Deferred Income Tax | 26.76M | 0 | 0 | 0 | (30.8M) |
| Stock-Based Compensation | 55.47K | 391.63K | 0 | 0 | 0 |
| Change in Working Capital | 21.11M | (2.56M) | (1.17M) | 2.06M | 3.02M |
| Accounts Receivables | (25.43K) | 13.89K | (8.1M) | 327.19K | (859.54K) |
| Inventory | 20.52M | (7.8M) | 6.11M | 1.5M | 0 |
| Accounts Payables | (82.1K) | (104.24K) | 712.89K | 166.05K | 417.18K |
| Other Working Capital | 700.15K | 76.29K | 102.42K | 67.96K | 3.46M |
| Other Non-Cash Items | (3.16M) | 10.38M | 11M | 8.41M | 162.28M |
| Operating Cash Flow | 10.06M | (8.63M) | (3.25M) | 1.35M | 1.18M |
| Capital Expenditures | 0 | (4.86K) | 0 | 0 | (154.46K) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | (93.75M) |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | (662) | (19.96M) | 18.47M | (54.72M) | (12.01M) |
| Investing Cash Flow | (662) | (19.96M) | 18.47M | (54.72M) | (105.91M) |
| Debt Repayment | (10M) | (10M) | (27.51M) | (7.69M) | 0 |
| Common Stock Issued | 5 | 10.02M | 0 | 139.34M | 195.88M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 962.77K | 34.76M | 0 | 0 | 0 |
| Financing Cash Flow | (9.04M) | 34.78M | (27.51M) | 131.65M | 195.88M |
| Effect of Forex Changes | 3.18M | 607.72K | (436.51K) | (1.27M) | (1.12M) |
| Net Change in Cash | 4.2M | 6.8M | (12.73M) | 77.01M | 90.03M |
| Free Cash Flow | 10.06M | (8.63M) | (3.25M) | 1.35M | 1.02M |
Akso Health Group
NASDAQ:AHG
Intrinsic Alpha fair value
Locked
Current Price
$1.36
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.